Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DECIPHERA PHARMACEUTICALS, INC.

(DCPH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about DECIPHERA PHARMACEUTICALS, INC.
01/24DECIPHERA PHARMACEUTICALS : Presents Results from the INTRIGUE Phase 3 Clinical Study at t..
PU
01/24Deciphera Pharmaceuticals Presents Results from the INTRIGUE Phase 3 Clinical Study at ..
BU
01/24Deciphera Pharmaceuticals, Inc. Presents Results from the INTRIGUE Phase 3 Clinical Stu..
CI
01/10DECIPHERA PHARMACEUTICALS : Provides Corporate Update and Highlights Key 2022 Corporate Mi..
PU
01/10Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2022 Corporate M..
BU
01/03Deciphera Pharmaceuticals, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Co..
BU
2021Deciphera Announces Approval of QINLOCK in the United Kingdom for the Treatment of Four..
AQ
2021Deciphera Wins UK Approval of Qinlock Inhibitor for Advanced Gastrointestinal Stromal T..
MT
2021Deciphera Announces Approval of QINLOCK« in the United Kingdom for the Treatment of Fou..
BU
2021Deciphera Announces Approval of QINLOCK« in the United Kingdom for the Treatment of Fou..
CI
2021Piper Sandler Adjusts Deciphera Pharmaceuticals' Price Target to $11 From $14, Maintain..
MT
2021HC Wainwright Adjusts Deciphera Pharmaceuticals' Price Target to $15 From $25, Reiterat..
MT
2021Deciphera to Cut Workforce by 35%; to Discontinue Rebastinib Program; to Extend Cash Ru..
MT
2021DECIPHERA PHARMACEUTICALS : Announces Restructuring to Prioritize Clinical Development Pro..
PU
2021Deciphera Pharmaceuticals, Inc. Announces Restructuring to Prioritize Clinical Developm..
CI
More most relevant news
All news about DECIPHERA PHARMACEUTICALS, INC.
01/24U.S. sees 'openness' in Mexico to resolving energy bill concerns
RE
01/24U.S. sees 'openness' in Mexico to resolving energy bill concerns
RE
01/24DECIPHERA PHARMACEUTICALS : Presents Results from the INTRIGUE Phase 3 Clinical Study at t..
PU
01/24DECIPHERA PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhib..
AQ
01/24Deciphera Pharmaceuticals Presents Results from the INTRIGUE Phase 3 Clinical Study at ..
BU
01/24Deciphera Pharmaceuticals, Inc. Presents Results from the INTRIGUE Phase 3 Clinical Stu..
CI
01/20Mexico power bill in U.S. sights as Granholm makes case for renewables
RE
01/20Mexican power bill in U.S. sights as top energy official meets Lopez Obrador
RE
01/14In Cuba's poorest neighborhoods, youths could face decades in jail after protests
RE
01/10DECIPHERA PHARMACEUTICALS : Provides Corporate Update and Highlights Key 2022 Corporate Mi..
PU
More news
News in other languages on DECIPHERA PHARMACEUTICALS, INC.
01/24Deciphera Pharmaceuticals, Inc. présente les résultats de l'étude clinique de phase 3 I..
01/14En los barrios más pobres de Cuba, jóvenes podrían enfrentar décadas de cárcel tras las..
2021Deciphera obtient l'autorisation du Royaume-Uni pour l'inhibiteur Qinlock dans le trait..
2021Deciphera annonce l'approbation de QINLOCK« au Royaume-Uni pour le traitement de la tum..
2021Barbados renuncia a la reina de Inglaterra para convertirse en una república
2021Deciphera Pharmaceuticals obtient le feu vert de l'UE pour son médicament Qinlock contr..
2021Les actions du secteur de la santé en difficulté vendredi dans un contexte de reprise d..
2021Les actions du secteur de la santé en baisse vendredi
2021Earnings Flash (DCPH) DECIPHERA PHARMACEUTICALS affiche un chiffre d'affaires de 23,2 m..
2021Les actions du secteur de la santé prolongent leur repli avant la clôture de mardi
More news
Analyst Recommendations on DECIPHERA PHARMACEUTICALS, INC.
2021Piper Sandler Adjusts Deciphera Pharmaceuticals' Price Target to $11 From $14, Maintain..
MT
2021HC Wainwright Adjusts Deciphera Pharmaceuticals' Price Target to $15 From $25, Reiterat..
MT
2021JPMorgan Adjusts Price Target on Deciphera Pharmaceuticals to $10 From $43, Maintains N..
MT
2021Barclays Downgrades Deciphera Pharmaceuticals to Equal-Weight Rating From Overweight, A..
MT
2021HC Wainwright Adjusts Price Target on Deciphera Pharmaceuticals to $25 from $70, Keeps ..
MT
More recommendations
Press releases
01/24DECIPHERA PHARMACEUTICALS : Presents Results from the INTRIGUE Phase 3 Clinical Study at t..
PU
01/24DECIPHERA PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhib..
AQ
01/24Deciphera Pharmaceuticals Presents Results from the INTRIGUE Phase 3 Clinical Study at ..
BU
01/10DECIPHERA PHARMACEUTICALS : Provides Corporate Update and Highlights Key 2022 Corporate Mi..
PU
01/10DECIPHERA PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhib..
AQ
More press releases
Upcoming event on DECIPHERA PHARMACEUTICALS, INC.